Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-17-000923
Filing Date
2017-04-05
Accepted
2017-04-05 14:04:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO THE SCHEDULE 13D sc13da507352007_04052017.htm SC 13D/A 237353
  Complete submission text file 0000921895-17-000923.txt   239188
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43381 | Film No.: 17742097
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022 212-319-1309
KINGSTOWN CAPITAL PARTNERS, LLC (Filed by) CIK: 0001418673 (see all company filings)

EIN.: 743125312 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A